Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 67

Sort by

Sort Order Select

Journal Articles

Targeting WDR5/ATAD2 signaling by the CK2/Ikaros axis demonstrates therapeutic efficacy in T-ALL

Qi Han, Yan Gu, Huimin Xiang, Linyao Zhang, Yan Wang, Chan Yang, Jun Li, Chelsea Steiner, Rosa Lapalombella, Jennifer A. Woyach, Yiping Yang, Sinisa Dovat, Chunhua Song, Zheng Ge

Blood blood.2024024130.

https://doi.org/10.1182/blood.2024024130

Published: 2024

Includes: Supplemental data

Journal Articles

A Multicenter Study on Front-Line Treatment of Diffuse Large B-Cell Lymphoma with Zanubrutinib Combination Therapy

Jun Li, Qian Zhang, Bo Lu, Xiaoqing Li, Jihao Zhou, Lina Hu

Blood (2024) 144 (Supplement 1): 6491.

https://doi.org/10.1182/blood-2024-201892

Published: 2024

Journal Articles

Development of ThisCART371 Targeting CLL1 for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

Xiaomei Zhang, Xia Xiao, Hairong Lv, Xue Bai, Pengjiang Liu, Yedi Pu, Juanxia Meng, Haibo Zhu, Zhao Wang, Huan Zhang, Xiaoyuan He, Yu Zhang, Cuicui Lv, Yifan Zhao, Shujing Guo, Jile Liu, Mohan Zhao, Jun Li, Mingfeng Zhao

Blood (2024) 144 (Supplement 1): 7210.

https://doi.org/10.1182/blood-2024-204381

Published: 2024

Journal Articles

Protein and Gene Levels of DNAJC21 and RNF5 Proven to be Novel Drug Targets for Immune Thrombocytopenia: Insights from Mendelian Randomization-Based Post-GWAS Research

Jun Li, Xiaoli Li, Xiaofan Zhu

Blood (2024) 144 (Supplement 1): 2561.

https://doi.org/10.1182/blood-2024-198781

Published: 2024

Journal Articles

Multi-Omic Transcription Regulatory Network Mapping Identifies Targetable Oncogenic TF-Cofactor Relationship between IRF4 and p300 in Multiple Myeloma, and Is Used to Improve TF Protein-Protein Interaction Methodology

Yupeng Zheng, Walter F Lenoir, Marek J Kobylarz, Jun Li, Tamara D Hopkins, Michael R McKeown, Michelle G. Shum, Kameron R Mori, Elizabeth C Townsend, Benjamin W Trotter, Peter B Rahl, Nikolaus D Obholzer, Charles Y Lin

Blood (2024) 144 (Supplement 1): 4970.

https://doi.org/10.1182/blood-2024-210684

Published: 2024

Journal Articles

Identification of Novel Genes Underlying Human AML Expansion at Relapse from Chemotherapy

Darren King, Kai Wu, Qianyi Ma, Josephine Dubois, Xianing Zheng, Mohamed Rizk, Kerby Shedden, Malathi Kandarpa, Dan Boyer, Karan Bedi, Jun Li, Sami N. Malek

Blood (2024) 144 (Supplement 1): 1528.

https://doi.org/10.1182/blood-2024-197941

Published: 2024

Journal Articles

Distinguishing Childhood Non-Severe Aplastic Anemia from Dyskeratosis Congenita through Telomere Length Analysis

Zixi Yin, Xiaofan Zhu, Yang Wan, Yangyang Gao, Jun Li

Blood (2024) 144 (Supplement 1): 1322.

https://doi.org/10.1182/blood-2024-206819

Published: 2024

Journal Articles

Ras-Associated Autoimmune Lymphoproliferative Disorder: Retrospective Case Series

Jianing Ren, Yang Wan, Yang Lan, Xiaolan Li, Jun Li, Li Zhang, Yumei Chen, Tianfeng Liu, Wenyu Yang, Xiaofan Zhu

Blood (2024) 144 (Supplement 1): 1162.

https://doi.org/10.1182/blood-2024-206929

Published: 2024

Journal Articles

AML Blasts Intrinsic Interferon Production Causes Resistance to Venetoclax in Human Acute Myeloid Leukemia Via Upregulation of MCL1, BCL2A1 and BCL-XL

Josephine Dubois, Kai Wu, Darren King, Xianing Zheng, Qianyi Ma, Karan Bedi, Jun Li, Sami N. Malek

Blood (2024) 144 (Supplement 1): 4151.

https://doi.org/10.1182/blood-2024-203424

Published: 2024

Journal Articles

HSC/MPP-like Signature Predicts Inferior Outcome of Multiple Pediatric Leukemias

Jingliao Zhang, Suyu Zong, Yongjuan Duan, Bei-bei Zhao, Jun Li, Xiaoli Chen, Wenyu Yang, Peng Wu, Xiaofan Zhu, Yingchi Zhang

Blood (2024) 144 (Supplement 1): 2833.

https://doi.org/10.1182/blood-2024-205638

Published: 2024

Journal Articles

Intracellular Retention of Tcrαβ/CD3 to Generate Novel Allogeneic CAR-T Cells (ThisCART19A) with Enhanced Antitumor Potency for Treating B-ALL

Yongxian HU, Guoqing Wei, Shan Fu, Pingnan Xiao, Jingjing Feng, Mingming Zhang, Xingbing Wang, Dongrui Wang, Jun Li, He Huang

Blood (2023) 142 (Supplement 1): 2111.

https://doi.org/10.1182/blood-2023-189052

Published: 2023

Journal Articles

Preclinical Evaluation of INCB160058 - a Novel and Potentially Disease-Modifying Therapy for JAK2V617F Mutant Myeloproliferative Neoplasms

Blood (2023) 142 (Supplement 1): 860.

https://doi.org/10.1182/blood-2023-179369

Published: 2023

Journal Articles

Azacitidine Combined with Novel Flavonoid Derivative GL-V9 Demonstrated Synergistic Anti-Leukemia Effect in Acute Myeloid Leukemia By Targeting DDIT4/mTOR Signaling

Jun Li, Qinglong Guo, Hui Hui, Hui Li, Chunhua Song, Zheng Ge

Blood (2023) 142 (Supplement 1): 5686.

https://doi.org/10.1182/blood-2023-185714

Published: 2023

Journal Articles

Dual Targeting Novel WDR5/ATAD2 Oncogenic Signaling through CK2/Ikaros Axis Demonstrates Synergistic Efficacy in T-ALL

Qi Han, Yan Gu, Chan Yang, Jun Li, Sinisa Dovat, Chunhua Song, Zheng Ge

Blood (2023) 142 (Supplement 1): 4188.

https://doi.org/10.1182/blood-2023-182745

Published: 2023

Journal Articles

Azacitidine Combined with Homoharringtonine, Idarubicin/Daunorubicin, Cytarabine for Previously Untreated Patients with Acute Myeloid Leukemia: A Single-Center, Phase 2 Study

Jun Li, Yanqing Huang, Yue Hou, Jie Zi, Chunhua Song, Zheng Ge

Blood (2022) 140 (Supplement 1): 3273–3274.

https://doi.org/10.1182/blood-2022-164898

Published: 2022

Journal Articles

CX43-Mediated Mitochondria Transfer from Bone Marrow Stromal Cells Promotes the Stemness of Leukemia Stem Cells

Huihui Fu, Xiaomei Zhang, Sanxiu He, Jun Li, Yao Liu

Blood (2022) 140 (Supplement 1): 3373.

https://doi.org/10.1182/blood-2022-159856

Published: 2022

Journal Articles

Efficacy and Safety of Zanubrutinib Combined with R-CHOP Regimen in the Treatment of Newly Diagnosed Diffuse Large B-Cell Lymphoma with Extranodal Involvement: A Single-Arm, Prospective Phase II Trial

Blood (2022) 140 (Supplement 1): 9540–9541.

https://doi.org/10.1182/blood-2022-168308

Published: 2022

Journal Articles

Efficacy and Safety of Polatuzumab Vedotin in Combination with Rituximab Plus Bendamustine in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Single Center Analysis of Pola Compassionate Use Program (CUP) in China

Tao Yang, Jun Li, Lingqian Zhang, Renzhi Hu, Jing Wu, Yao Ding, Xiping Liang, Xi Quan, Chongling Hu, Wenjun Zhang, Bingling Guo, Chaoyu Wang, Qiying Li, Jieping Li, Yingyu Nan, Ying Xiang, Yao Liu

Blood (2022) 140 (Supplement 1): 12139.

https://doi.org/10.1182/blood-2022-168656

Published: 2022

Journal Articles

High Efficacy of Azacitidine Plus Hag in Acute Myeloid Leukemia: A Multi-Center, Phase 2 Clinical Trial

Blood (2022) 140 (Supplement 1): 6167–6169.

https://doi.org/10.1182/blood-2022-164649

Published: 2022

Journal Articles

Clinical Feature and Effect of Demethylation Therapy in Pediatric Patients with Acute Myeloid Leukemia with Myelodysplasia-Related Changes

Yang Wan, Ranran Zhang, Min Ruan, Jun Li, Xiaolan Li, Xiaoyan Zhang, Xiaojuan Chen, Li Zhang, Yao Zou, Yumei Chen, Ye Guo, Wenyu Yang, Xiaofan Zhu

Blood (2022) 140 (Supplement 1): 11628–11629.

https://doi.org/10.1182/blood-2022-168436

Published: 2022

NARROW

Targeting WDR5/ATAD2 signaling by the CK2/Ikaros axis demonstrates therapeutic efficacy in T-ALL

A Multicenter Study on Front-Line Treatment of Diffuse Large B-Cell Lymphoma with Zanubrutinib Combination Therapy

Development of ThisCART371 Targeting CLL1 for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

Protein and Gene Levels of DNAJC21 and RNF5 Proven to be Novel Drug Targets for Immune Thrombocytopenia: Insights from Mendelian Randomization-Based Post-GWAS Research

Multi-Omic Transcription Regulatory Network Mapping Identifies Targetable Oncogenic TF-Cofactor Relationship between IRF4 and p300 in Multiple Myeloma, and Is Used to Improve TF Protein-Protein Interaction Methodology

Identification of Novel Genes Underlying Human AML Expansion at Relapse from Chemotherapy

Distinguishing Childhood Non-Severe Aplastic Anemia from Dyskeratosis Congenita through Telomere Length Analysis

Ras-Associated Autoimmune Lymphoproliferative Disorder: Retrospective Case Series

AML Blasts Intrinsic Interferon Production Causes Resistance to Venetoclax in Human Acute Myeloid Leukemia Via Upregulation of MCL1, BCL2A1 and BCL-XL

HSC/MPP-like Signature Predicts Inferior Outcome of Multiple Pediatric Leukemias

Intracellular Retention of Tcrαβ/CD3 to Generate Novel Allogeneic CAR-T Cells (ThisCART19A) with Enhanced Antitumor Potency for Treating B-ALL

Preclinical Evaluation of INCB160058 - a Novel and Potentially Disease-Modifying Therapy for JAK2V617F Mutant Myeloproliferative Neoplasms

Azacitidine Combined with Novel Flavonoid Derivative GL-V9 Demonstrated Synergistic Anti-Leukemia Effect in Acute Myeloid Leukemia By Targeting DDIT4/mTOR Signaling

Dual Targeting Novel WDR5/ATAD2 Oncogenic Signaling through CK2/Ikaros Axis Demonstrates Synergistic Efficacy in T-ALL

Azacitidine Combined with Homoharringtonine, Idarubicin/Daunorubicin, Cytarabine for Previously Untreated Patients with Acute Myeloid Leukemia: A Single-Center, Phase 2 Study

CX43-Mediated Mitochondria Transfer from Bone Marrow Stromal Cells Promotes the Stemness of Leukemia Stem Cells

Efficacy and Safety of Zanubrutinib Combined with R-CHOP Regimen in the Treatment of Newly Diagnosed Diffuse Large B-Cell Lymphoma with Extranodal Involvement: A Single-Arm, Prospective Phase II Trial

Efficacy and Safety of Polatuzumab Vedotin in Combination with Rituximab Plus Bendamustine in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Single Center Analysis of Pola Compassionate Use Program (CUP) in China

High Efficacy of Azacitidine Plus Hag in Acute Myeloid Leukemia: A Multi-Center, Phase 2 Clinical Trial

Clinical Feature and Effect of Demethylation Therapy in Pediatric Patients with Acute Myeloid Leukemia with Myelodysplasia-Related Changes

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only